ACS DOBFAR SPA FDA Approval ANDA 064124

ANDA 064124

ACS DOBFAR SPA

FDA Drug Application

Application #064124

Application Sponsors

ANDA 064124ACS DOBFAR SPA

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 7.5GM BASE/VIAL0CEFUROXIME SODIUMCEFUROXIME SODIUM

FDA Submissions

ORIG1AP1997-05-30
LABELING; LabelingSUPPL3AP2004-09-30
LABELING; LabelingSUPPL5AP2007-01-31
LABELING; LabelingSUPPL6AP2007-06-20
LABELING; LabelingSUPPL7AP2007-11-16
LABELING; LabelingSUPPL8AP2008-07-31
LABELING; LabelingSUPPL18AP2021-10-08STANDARD

Submissions Property Types

SUPPL1Null0
SUPPL18Null15

TE Codes

001PrescriptionAP

CDER Filings

ACS DOBFAR SPA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 64124
            [companyName] => ACS DOBFAR SPA
            [docInserts] => ["",""]
            [products] => [{"drugName":"CEFUROXIME SODIUM","activeIngredients":"CEFUROXIME SODIUM","strength":"EQ 7.5GM BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CEFUROXIME SODIUM","submission":"CEFUROXIME SODIUM","actionType":"EQ 7.5GM BASE\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.